Travere Therapeutics, Inc.
TVTX • NASDAQ
Travere Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric Dube, with a market cap of $3.6B.
Market Cap$3.6B
Employees380.0
CEOEric Dube
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 6 daysAfter Market Close · Q1 2026
Financials
Travere Therapeutics, Inc. FAQ
Common questions about Travere Therapeutics, Inc.
Travere Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on April 30, 2026 after market close. Analysts estimate revenue of $136.2M.
Travere Therapeutics, Inc. has approximately 380 employees.